Proceedings: Concentrations of the oxime 2-hydroxyiminomethyl pyridinium methyl methane sulphonate (P2S) after intramuscular injections in humans.
D006801:Humans; D007273:Injections, Intramuscular; D008698:Mesylates / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology; D011220:Pralidoxime Compounds / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology; D013848:Thigh; D014786:Vision Disorders / Q000139:chemically induced
D008698:Mesylates; D011220:Pralidoxime Compounds